Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-08-15

Study Completion Date

2028-10-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Previous studies have indicated that 13C-MRS in the ultra-high 7T magnetic resonance (MR) field is a potential non-invasive measurement method for assessing changes in muscle glycogen levels in PoD patients. However, in a single study, increases in glycogen intermediates were observed using the even more sensitive 31P-MRS technique in a mouse model of PoD and in glycogen storage disease III in humans. In fact, glycolytic intermediates such as phosphomonoesters (PME), measured by phosphorus-31P-MRS in PoD mouse models, were superior to 13C-MRS in monitoring disease progression and quantifying glycogen, indicating a significant clinical potential of 31P-MRS in humans. It has been shown that 31P-MRS can reliably quantify age- and weight-related differences as well as changes in thyroid function in human muscle metabolism. This study conducted by our institute demonstrates that the technique possesses the necessary sensitivity to measure these subtle muscular metabolic changes. However, there are currently no human 31P-MRS muscle data available for PoD. Therefore, we propose a proof-of-principle study to address this knowledge gap and contribute to establishing a new sensitive muscular biomarker that quantifies the primary disease mechanism, namely glycogen formation, for future longitudinal studies on PoD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Natural History Study of Adult Onset Pompe Disease Using Muscle MRI

NCT01914536

Pompe Disease

UNKNOWN

Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy

NCT06137612

Spinal Muscular Atrophy Type III Spinal Muscular Atrophy Type II

ENROLLING_BY_INVITATION

Evaluation of Optical Pumping Magnetometer Sensors for MagnetoEncephaloGraphy Imaging

NCT04694313

Epilepsy

COMPLETED NA

Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS)

NCT01945853

Amyotrophic Lateral Sclerosis (ALS)

WITHDRAWN NA

Feasibility Testing of 7-Tesla Magnetic Resonance Imaging

NCT05992298

Magnetic Resonance Imaging

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pompe Disease McArdle Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy controls

negative controls

Siemens Magnetom 7T Plus

Intervention Type DEVICE

Magnetic Resonance Spectroscopy

Pompe Disease patients

Siemens Magnetom 7T Plus

Intervention Type DEVICE

Magnetic Resonance Spectroscopy

McArdle Disease patients

positiv controls

Siemens Magnetom 7T Plus

Intervention Type DEVICE

Magnetic Resonance Spectroscopy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Siemens Magnetom 7T Plus

Magnetic Resonance Spectroscopy

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients with PoD and McArdle disease:

* age between 18-70
* Confirmed diagnosis: enzyme activity and/or genetic testing
* body weight \> 40kg at screening
* 6-minute walking distance \> 75m at screening (only PoD patients)
* Sitting FCV ≥ 30% predicted (only PoD patients)
* "Informed Consent" issued orally and in writing

Healthy volunteers (controls):

• age between 18-70

Exclusion Criteria

Patients with PoD and McArdle disease:

* pregnancy (will be assessed prior to MRS measurements using a rapid pregnancy test)
* Involvement of the respiratory musculature
* claustrophobia
* active participation in another clinical trial
* metal devices or other magnetic material in or on the subjects body which will be hazardous for NMR investigation \[heart pacemaker, coronary stents and heart valves (in case these devices are not compatible with a 7T MRI), brain (aneurysm) clip, nerve stimulators, electrodes, ear implants, penile implants, colored contact lenses, patch to deliver medications through the skin, coiled spring intrauterine device, vascular filter for blood clots, orthodontic braces, shunt-spinal or ventricular, any metal implants (rods, joints, plates, pins, screws, nails, or clips), embolization coil, or any metal fragments or shrapnel in the body.

Healthy volunteers (controls):

* any known endocrine, metabolic or neurological disorder
* special diets especially ketogenic or atkins diet
* creatine supplementation
* pregnancy (will be assessed prior to MRS measurements using a rapid pregnancy test)
* claustrophobia
* active participation in another clinical trial
* metal devices or other magnetic material in or on the subjects body which will be hazardous for NMR investigation \[heart pacemaker, coronary stents and heart valves (in case these devices are not compatible with a 7T MRI), brain (aneurysm) clip, nerve stimulators, electrodes, ear implants, penile implants, colored contact lenses, patch to deliver medications through the skin, coiled spring intrauterine device, vascular filter for blood clots, orthodontic braces, shunt-spinal or ventricular, any metal implants (rods, joints, plates, pins, screws, nails, or clips), embolization coil, or any metal fragments or shrapnel in the body.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No